Search Results

There are 2406 results for: content related to: A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder

  1. You have free access to this content
    Ziprasidone for Schizophrenia and Bipolar Disorder: A Review of the Clinical Trials

    CNS Drug Reviews

    Volume 13, Issue 2, June 2007, Pages: 137–177, William M. Greenberg and Leslie Citrome

    Version of Record online : 9 JUN 2007, DOI: 10.1111/j.1527-3458.2007.00008.x

  2. Ziprasidone for schizophrenia and severe mental illness

    Intervention Review

    The Cochrane Library

    Anne-Marie Bagnall, Jos Kleijnen, Maria Leitner and Ruth Lewis

    Published Online : 23 OCT 2000, DOI: 10.1002/14651858.CD001945

  3. Ziprasidone versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Sandra Schwarz, Paranthaman Sethupathi Bhoopathi, Werner Kissling and Stefan Leucht

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD006627.pub2

  4. Effect of cyclodextrin derivation and amorphous state of complex on accelerated degradation of ziprasidone

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 7, July 2011, Pages: 2703–2716, Jinyang Hong, Jaymin C. Shah and Maura D. Mcgonagle

    Version of Record online : 31 JAN 2011, DOI: 10.1002/jps.22498

  5. Molecular dynamics of the cryomilled base and hydrochloride ziprasidones by means of dielectric spectroscopy

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 7, July 2011, Pages: 2642–2657, K. Kaminski, K. Adrjanowicz, Z. Wojnarowska, K. Grzybowska, L. Hawelek, M. Paluch, D. Zakowiecki and J. Mazgalski

    Version of Record online : 26 JAN 2011, DOI: 10.1002/jps.22479

  6. You have free access to this content
    Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions

    British Journal of Clinical Pharmacology

    Volume 49, Issue S1, January 2000, Pages: 35–42, C. Prakash, A. Kamel, D. Cui, R. D. Whalen, J. J. Miceli and D. Tweedie

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00151.x

  7. You have free access to this content
    The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid

    British Journal of Clinical Pharmacology

    Volume 49, Issue S1, January 2000, Pages: 57–60, K. D. Wilner, R. A. Hansen, C. J. Folger and P. Geoffroy

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00154.x

  8. You have free access to this content
    Ziprasidone in the Treatment of Affective Disorders: A Review

    CNS Neuroscience & Therapeutics

    Volume 14, Issue 4, Winter 2008, Pages: 278–286, Adriane R Rosa, Carolina Franco, Carla Torrent, Mercè Comes, Nuria Cruz, Guillermo Horga, Antonio Benabarre and Eduard Vieta

    Version of Record online : 11 NOV 2008, DOI: 10.1111/j.1755-5949.2008.00056.x

  9. Olanzapine versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Lorna Duggan, Werner Kissling and Stefan Leucht

    Published Online : 17 MAR 2010, DOI: 10.1002/14651858.CD006654.pub2

  10. Comparison of the metabolic and economic consequences of long-term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost-effectiveness analysis

    Journal of Evaluation in Clinical Practice

    Volume 16, Issue 4, August 2010, Pages: 744–755, Roger S. McIntyre, Lael Cragin, Sonja Sorensen, Huseyin Naci, Tim Baker and Jean-Pascal Roussy

    Version of Record online : 10 JUN 2010, DOI: 10.1111/j.1365-2753.2009.01189.x

  11. Pharmacokinetics, Safety, and Tolerability of Intramuscular Ziprasidone in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 45, Issue 6, June 2005, Pages: 620–630, Dr Jeffrey J. Miceli, Dr Keith D. Wilner, Dr Suzanne K. Swan and Mr Thomas G. Tensfeldt

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005276485

  12. You have free access to this content
    The effects of ketoconazole on ziprasidone pharmacokinetics —a placebo-controlled crossover study in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 49, Issue S1, January 2000, Pages: 71–76, J. J. Miceli, M. Smith, L. Robarge, T. Morse and A. Laurent

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00156.x

  13. Preparation and evaluation of ziprasidone–phospholipid complex from sustained-release pellet formulation with enhanced bioavailability and no food effect

    Journal of Pharmacy and Pharmacology

    Volume 68, Issue 2, February 2016, Pages: 185–194, Yanfei Miao, Guoguang Chen, Lili Ren and Pingkai Ouyang

    Version of Record online : 8 JAN 2016, DOI: 10.1111/jphp.12510

  14. You have free access to this content
    The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function

    British Journal of Clinical Pharmacology

    Volume 49, Issue S1, January 2000, Pages: 21–26, G. Everson, K. C. Lasseter, K. E. Anderson, L. A. Bauer, R. L. Carithens Jr, K. D. Wilner, A. Johnson, R. J. Anziano, T. A. Smolarek and R. Z. Turncliff

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00149.x

  15. You have free access to this content
    Aripiprazole versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Priya Khanna, Tao Suo, Katja Komossa, Huaixing Ma, Christine Rummel-Kluge, Hany G El-Sayeh, Stefan Leucht and Jun Xia

    Published Online : 2 JAN 2014, DOI: 10.1002/14651858.CD006569.pub5

  16. You have free access to this content
    The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function

    British Journal of Clinical Pharmacology

    Volume 49, Issue S1, January 2000, Pages: 27–33, F. Aweeka, D. Jayesekara, M. Horton, S. Swan, L. Lambrecht, K. D. Wilner, J. Sherwood, R. J. Anziano, T. A. Smolarek, & and R. Z. Turncliff

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00150.x

  17. You have free access to this content
    The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 49, Issue S1, January 2000, Pages: 65–70, J. J. Miceli, R. J. Anziano, L. Robarge, R. A. Hansen and A. Laurent

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00157.x

  18. You have free access to this content
    Ziprasidone and the pharmacokinetics of a combined oral contraceptive

    British Journal of Clinical Pharmacology

    Volume 49, Issue S1, January 2000, Pages: 49–56, G. J. Muirhead, J. Harness, P. R. Holt, S. Oliver and R. J. Anziano

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00153.x

  19. You have free access to this content
    Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers

    British Journal of Clinical Pharmacology

    Volume 49, Issue S1, January 2000, Pages: 43–47, K. D. Wilner, S. B. Demattos, R. J. Anziano, G. Apseloff, & and N. Gerber

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00152.x

  20. Amisulpride versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Joaquim I Silveira da Mota Neto, Werner Kissling and Stefan Leucht

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD006624.pub2